News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
186,532 Results
Type
Article (7871)
Company Profile (18)
Press Release (178643)
Multimedia
Podcasts (5)
Webinars (3)
Section
Business (49506)
Career Advice (554)
Deals (7667)
Drug Delivery (40)
Drug Development (32166)
Employer Resources (32)
FDA (5088)
Job Trends (4491)
News (95253)
Policy (8341)
Tag
Academia (546)
Accelerated approval (12)
Adcomms (6)
Allergies (47)
Alliances (12908)
ALS (52)
Alzheimer's disease (532)
Antibody-drug conjugate (ADC) (134)
Approvals (5313)
Artificial intelligence (90)
Autoimmune disease (45)
Automation (9)
Bankruptcy (58)
Best Places to Work (3307)
BIOSECURE Act (3)
Biosimilars (68)
Biotechnology (11)
Bladder cancer (70)
Brain cancer (15)
Breast cancer (222)
Cancer (1698)
Cardiovascular disease (100)
Career advice (478)
Career pathing (5)
CAR-T (91)
CDC (6)
Cell therapy (215)
Cervical cancer (12)
Clinical research (28719)
Collaboration (408)
Compensation (78)
Complete response letters (17)
COVID-19 (930)
CRISPR (17)
C-suite (108)
Cystic fibrosis (67)
Data (2422)
Denatured (1)
Depression (35)
Diabetes (126)
Diagnostics (1129)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (6)
Drug discovery (52)
Drug pricing (17)
Drug shortages (10)
Duchenne muscular dystrophy (62)
Earnings (24460)
Editorial (9)
Employer branding (2)
Employer resources (26)
Events (24920)
Executive appointments (122)
FDA (6182)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (6)
Funding (257)
Gene editing (47)
Generative AI (8)
Gene therapy (149)
GLP-1 (234)
Government (896)
Grass and pollen (3)
Guidances (122)
Healthcare (3959)
HIV (18)
Huntington's disease (11)
IgA nephropathy (38)
Immunology and inflammation (67)
Immuno-oncology (18)
Indications (37)
Infectious disease (1007)
Inflammatory bowel disease (59)
Inflation Reduction Act (1)
Influenza (32)
Intellectual property (54)
Interviews (85)
IPO (2905)
Job creations (1354)
Job search strategy (434)
JPM (5)
Kidney cancer (7)
Labor market (21)
Layoffs (172)
Leadership (5)
Legal (1542)
Liver cancer (30)
Lung cancer (213)
Lymphoma (154)
Machine learning (14)
Management (12)
Manufacturing (386)
MASH (28)
Medical device (2574)
Medtech (2590)
Mergers & acquisitions (5024)
Metabolic disorders (281)
Multiple sclerosis (47)
NASH (4)
Neurodegenerative disease (81)
Neuropsychiatric disorders (11)
Neuroscience (873)
NextGen: Class of 2026 (1080)
Non-profit (571)
Now hiring (9)
Obesity (134)
Opinion (32)
Ovarian cancer (95)
Pain (70)
Pancreatic cancer (72)
Parkinson's disease (100)
Partnered (7)
Patents (91)
Patient recruitment (255)
Peanut (21)
People (10062)
Pharmaceutical (7)
Pharmacy benefit managers (3)
Phase 1 (8274)
Phase 2 (12555)
Phase 3 (10180)
Pipeline (1758)
Policy (23)
Postmarket research (1059)
Preclinical (2942)
Press Release (16)
Prostate cancer (94)
Psychedelics (7)
Radiopharmaceuticals (102)
Rare diseases (259)
Real estate (2608)
Recruiting (13)
Regulatory (7313)
Reports (11)
Research institute (597)
Resumes & cover letters (71)
Rett syndrome (19)
RNA editing (4)
RSV (24)
Schizophrenia (35)
Series A (39)
Series B (25)
Service/supplier (3)
Sickle cell disease (27)
Special edition (9)
Spinal muscular atrophy (43)
Sponsored (21)
Startups (699)
Stomach cancer (7)
Supply chain (36)
Tariffs (28)
The Weekly (4)
Vaccines (264)
Venture capital (11)
Weight loss (71)
Women's health (19)
Worklife (7)
Date
Today (3)
Last 7 days (140)
Last 30 days (555)
Last 365 days (7864)
2026 (694)
2025 (7914)
2024 (8813)
2023 (9956)
2022 (12458)
2021 (13957)
2020 (13206)
2019 (9373)
2018 (6952)
2017 (7025)
2016 (6506)
2015 (7829)
2014 (5582)
2013 (4412)
2012 (4941)
2011 (5398)
2010 (5759)
Location
Africa (196)
Alabama (15)
Alaska (2)
Arizona (45)
Arkansas (3)
Asia (11044)
Australia (2049)
California (2629)
Canada (803)
China (367)
Colorado (88)
Connecticut (142)
Delaware (93)
Europe (21668)
Florida (433)
Georgia (70)
Hawaii (2)
Idaho (7)
Illinois (243)
India (33)
Indiana (148)
Iowa (9)
Japan (168)
Kansas (29)
Kentucky (6)
Louisiana (6)
Maine (4)
Maryland (340)
Massachusetts (2132)
Michigan (67)
Minnesota (144)
Mississippi (1)
Missouri (25)
Montana (3)
Nebraska (7)
Nevada (30)
New Hampshire (12)
New Jersey (1068)
New Mexico (4)
New York (718)
North Carolina (444)
North Dakota (1)
Northern California (1352)
Ohio (122)
Oklahoma (2)
Oregon (13)
Pennsylvania (603)
Puerto Rico (7)
Rhode Island (9)
South America (242)
South Carolina (19)
Southern California (964)
Tennessee (50)
Texas (403)
United States (10181)
Utah (58)
Virginia (66)
Washington D.C. (19)
Washington State (283)
West Virginia (2)
Wisconsin (21)
186,532 Results for "binding site".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint • Building permit application for German site submitted • Construction start is scheduled for the 2nd quarter 2026, with operational readiness in 2031 • Expansions in the US and Europe are included in a €1.5 billion investment plan
January 29, 2026
·
1 min read
Spinal muscular atrophy
Much Maligned Manufacturing Site Trips Up Scholar Rock’s Spinal Muscular Atrophy Drug
In its rejection letter, the FDA flagged problems at a third-party fill-finish site owned by Novo Nordisk. Issues at this site have previously been investigated by the regulator.
September 23, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bachem Announces Progress in Building K Start-Up and Expansion of Its Site in Vista, CA
• The capacity expansion in Bubendorf reached another important milestone with the inspection of Building K. The announced start-up is proceeding according to plan. • In Vista, CA, Bachem acquired a property adjacent to its existing facility. The acquisition will enable a future capacity expansion at the Vista site, thereby strengthening Bachem’s presence in the US market.
October 23, 2025
·
2 min read
Press Releases
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites
February 2, 2026
·
2 min read
Layoff Tracker
Charles River, Thermo Fisher Lay Off Staff Amid Site Closures
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
February 6, 2026
·
51 min read
·
BioSpace Editorial Staff
Press Releases
AGC Biologics Seattle Site Now Certified to Manufacture Biologics for Largest Pharmaceutical Market in South America
February 4, 2026
·
4 min read
Press Releases
Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony
Pharmaceutical service provider expands its footprint in the greater Chicago area · Production site expected to be ready for media fill by the end of 2029 · Modern site with holistic approach for state-of-the-art manufacturing operations · Fulfills the requirements for increased capacity in early clinical filling
June 27, 2025
·
1 min read
Press Releases
Evotec Closes Sale of Just - Evotec Biologics’ Toulouse Site to Sandoz
December 8, 2025
·
5 min read
Press Releases
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
January 27, 2026
·
3 min read
Press Releases
START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site
January 27, 2026
·
4 min read
1 of 18,654
Next